A. O. U. Federico II

Running trials

• Recruiting

  Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer

  NCT07389265· Phase 3· Source

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Source

• Recruiting

  Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD

  NCT05924100· Phase 2· Source

• Recruiting

  A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)

  NCT05001087· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of Vedolizumab in Adults With Crohn's Disease (CD)

  NCT05192863· Source

• Completed

  Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

  NCT05393024· Source

• Completed

  A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

  NCT03126019· Phase 2· Source

• Completed

  A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

  NCT03235544· Phase 2· Source